ConductScience.org, home

Paper32707656

Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.

Nakano Y and 5 others. Int J Mol Sci, 2020. Cited by 27 papers, by iCite.

Cite this record

ConductScience Library. Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model. Papers, record 32707656. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32707656

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Combination of Peroxisome Proliferator-Activated Receptor (PPAR) Alpha and Gamma Agonists Prevents Corneal Inflammation and Neovascularization in a Rat Alkali Burn Model.
PubMed
Journal
Int J Mol Sci
PubMed
Year
2020
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
27
iCite
Relative citation ratio, by iCite
1.77
iCite
Revised in PubMed
2021-02-16
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nakano YYuji
2Arima TTakeshihttps://orcid.org/0000-0003-1006-4430
3Tobita YYutaro
4Uchiyama MMasaaki
5Shimizu AAkirahttps://orcid.org/0000-0002-4364-9251
6Takahashi HHiroshi

Source PubMed

Download CSV of authors

Topics19

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Burns, ChemicalMajor topic
Corneal InjuriesMajor topic
Eye BurnsMajor topic
PPAR alphaMajor topic
PPAR gammaMajor topic
Animals
Corneal Neovascularization
Cytokines
Disease Models, Animal
Drug Therapy, Combination
Fenofibrate
Fibrosis
Keratitis
Male
Ophthalmic Solutions
Pioglitazone
RNA, Messenger
Rats
Rats, Wistar

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
19K18859Japan Society for the Promotion of SciencePubMed

Source PubMed

Download CSV of grants

References42

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
117681149PPARgamma activation primes human monocytes into alternative M2 macrophages with anti-inflammatory properties.Cell Metab2007https://conductscience.org/library/papers/17681149PubMed
212874451Lymphatic microvessels in the rat remnant kidney model of renal fibrosis: aminopeptidase p and podoplanin are discriminatory markers for endothelial cells of blood and lymphatic vessels.J Am Soc Nephrol2003https://conductscience.org/library/papers/12874451PubMed
38858144NF-kappa B: ten years after.Cell1996https://conductscience.org/library/papers/8858144PubMed
427713336Non-Steroidal Anti-Inflammatory Drugs and Brain Inflammation: Effects on Microglial Functions.Pharmaceuticals (Basel)2010https://conductscience.org/library/papers/27713336PubMed
531247081Rosiglitazone Treatment Prevents Postoperative Fibrosis in a Rabbit Model of Glaucoma Filtration Surgery.Invest Ophthalmol Vis Sci2019https://conductscience.org/library/papers/31247081PubMed
626145225Corneal structure and transparency.Prog Retin Eye Res2015https://conductscience.org/library/papers/26145225PubMed
718982158Macrophage diversity in renal injury and repair.J Clin Invest2008https://conductscience.org/library/papers/18982158PubMed
832353564Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist.Bioorg Chem2020https://conductscience.org/library/papers/32353564PubMed
910085162Peroxisome proliferator-activated receptor gamma ligands are potent inhibitors of angiogenesis in vitro and in vivo.J Biol Chem1999https://conductscience.org/library/papers/10085162PubMed
1015721857Beneficial effects of PPAR-gamma ligands in ischemia-reperfusion injury, inflammation and shock.Cardiovasc Res2005https://conductscience.org/library/papers/15721857PubMed
1117970759Effects of combined PPARgamma and PPARalpha agonist therapy on reverse cholesterol transport in the Zucker diabetic fatty rat.Diabetes Obes Metab2008https://conductscience.org/library/papers/17970759PubMed
1223233252Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization.Invest Ophthalmol Vis Sci2013https://conductscience.org/library/papers/23233252PubMed
1317681144Macrophage polarization and insulin resistance: PPARgamma in control.Cell Metab2007https://conductscience.org/library/papers/17681144PubMed
149222084Cytokine expression in the alkali-burned cornea.Curr Eye Res1997https://conductscience.org/library/papers/9222084PubMed
1528935121Treatment of acute ocular chemical burns.Surv Ophthalmol2018https://conductscience.org/library/papers/28935121PubMed
1624194635An ophthalmic solution of a peroxisome proliferator-activated receptor gamma agonist prevents corneal inflammation in a rat alkali burn model.Mol Vis2013https://conductscience.org/library/papers/24194635PubMed
1717931953Progressive pulmonary fibrosis is mediated by TGF-beta isoform 1 but not TGF-beta3.Int J Biochem Cell Biol2008https://conductscience.org/library/papers/17931953PubMed
1812746275Minireview: lipid metabolism, metabolic diseases, and peroxisome proliferator-activated receptors.Endocrinology2003https://conductscience.org/library/papers/12746275PubMed
1926199136Stimulation of nuclear receptor peroxisome proliferator-activated receptor-γ limits NF-κB-dependent inflammation in mouse cystic fibrosis biliary epithelium.Hepatology2015https://conductscience.org/library/papers/26199136PubMed
209104767Chemical injuries of the eye: current concepts in pathophysiology and therapy.Surv Ophthalmol1997https://conductscience.org/library/papers/9104767PubMed

See all 42 referencesDownload CSV of references

Cited by20

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 27 citations.

PMIDTitleJournalYearIn PapersSource
42713229Fenofibrate in ophthalmology: therapeutic efficacy and mechanisms.J Pharm Pharm Sci2026https://conductscience.org/library/papers/42713229PubMed
42072091Chiglitazar Activates PPAR-α/γ to Suppress Oxidative Stress and Angiogenesis in Corneal Neovascularization.Antioxidants (Basel)2026https://conductscience.org/library/papers/42072091PubMed
41854210Nintedanib Eye Drops Inhibit Alkali Burn-Induced Corneal Neovascularization Via RAP1/MEK/ERK Signaling Pathway.Invest Ophthalmol Vis Sci2026https://conductscience.org/library/papers/41854210PubMed
41640824The Mechanistic Role of PPARγ in Wound Healing.PPAR Res2026https://conductscience.org/library/papers/41640824PubMed
41121132Transforming corneal alkali burn treatment: unveiling mechanisms and pioneering therapies from bench to bedside.J Transl Med2025https://conductscience.org/library/papers/41121132PubMed
40190631Unraveling PPARβ/δ nuclear receptor agonists via a drug-repurposing approach: HTVS-based ligand identification, molecular dynamics, pharmacokinetics, and in vitro anti-steatotic validation.RSC Adv2025https://conductscience.org/library/papers/40190631PubMed
39763659The role of PPAR in fungal keratitis.Front Immunol2024https://conductscience.org/library/papers/39763659PubMed
38993197Potential therapeutic effects of peroxisome proliferator-activated receptors on corneal diseases.Exp Biol Med (Maywood)2024https://conductscience.org/library/papers/38993197PubMed
38802470Trimebutine prevents corneal inflammation in a rat alkali burn model.Sci Rep2024https://conductscience.org/library/papers/38802470PubMed
38638288Hypoxia, hypoxia-inducible factors and inflammatory bowel diseases.Gastroenterol Rep (Oxf)2024https://conductscience.org/library/papers/38638288PubMed
38028511Research progress on animal models of corneal epithelial-stromal injury.Int J Ophthalmol2023https://conductscience.org/library/papers/38028511PubMed
36588740Fenofibrate suppresses corneal neovascularization by regulating lipid metabolism through PPARα signaling pathway.Front Pharmacol2022https://conductscience.org/library/papers/36588740PubMed
36445944Oral Peroxisome Proliferator-Activated Receptor-α Agonist Enhances Corneal Nerve Regeneration in Patients With Type 2 Diabetes.Diabetes2023https://conductscience.org/library/papers/36445944PubMed
36305579Therapeutic roles of PPARα activation in ocular ischemic diseases.Histol Histopathol2023https://conductscience.org/library/papers/36305579PubMed
36077171Prophylactic Instillation of Hydrogen-Rich Water Decreases Corneal Inflammation and Promotes Wound Healing by Activating Antioxidant Activity in a Rat Alkali Burn Model.Int J Mol Sci2022https://conductscience.org/library/papers/36077171PubMed
35687344PPAR-α Agonist Fenofibrate Ameliorates Sjögren Syndrome-Like Dacryoadenitis by Modulating Th1/Th17 and Treg Cell Responses in NOD Mice.Invest Ophthalmol Vis Sci2022https://conductscience.org/library/papers/35687344PubMed
34833044PPARα Modulation-Based Therapy in Central Nervous System Diseases.Life (Basel)2021https://conductscience.org/library/papers/34833044PubMed
33645625Defective expression of the peroxisome regulators PPARα receptors and lysogenesis with increased cellular senescence in the venous wall of chronic venous disorder.Histol Histopathol2021https://conductscience.org/library/papers/33645625PubMed
33504094Effects of Selective Peroxisome Proliferator Activated Receptor Agonists on Corneal Epithelial Wound Healing.Pharmaceuticals (Basel)2021https://conductscience.org/library/papers/33504094PubMed
33086679PPARα Agonist Oral Therapy in Diabetic Retinopathy.Biomedicines2020https://conductscience.org/library/papers/33086679PubMed

Download CSV of cited by

Genes2

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
PPARA5465PubTator's text mininghttps://conductscience.org/library/genes/5465NCBI Gene
PPARG5468PubTator's text mininghttps://conductscience.org/library/genes/5468NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/32707656

GET https://conductscience.org/api/papers/v1/32707656/references?page=2